filovirus
caus
sever
hemorrhag
fever
human
archetyp
viru
group
ebola
viru
respons
current
filoviru
epidem
west
africa
filovirus
infect
mammalian
cell
result
broad
speci
tropism
like
contribut
rapid
spread
viru
throughout
bodi
thorough
understand
filoviru
entri
event
facilit
develop
therapeut
critic
step
viral
life
cycl
review
summar
current
understand
filoviru
entri
discuss
recent
advanc
therapeut
strategi
target
entri
ebolaviru
marburgviru
member
filovirida
famili
envelop
negativesens
rna
virus
caus
sever
hemorrhag
fever
human
nonhuman
primat
nhp
four
identifi
ebolaviru
speci
ebola
viru
formerli
zair
ebola
viru
ebov
bundibugyo
viru
sudan
viru
forest
viru
associ
episod
hemorrhag
fever
outbreak
subsaharan
africa
ebov
caus
current
west
africa
epidem
individu
thought
infect
epidem
fifth
ebolaviru
member
found
philippin
reston
viru
pathogen
nonhuman
primat
approv
vaccin
antivir
current
avail
virus
current
outbreak
emphas
critic
need
develop
treatment
filovirus
infect
wide
array
human
primari
cell
cell
line
dendrit
cell
dc
macrophag
major
earli
sustain
target
infect
viral
replic
cell
thought
amplifi
viru
within
infect
host
lead
system
spread
broad
array
cell
popul
rang
hepatocyt
endotheli
cell
fibroblast
lymphocyt
one
cell
type
product
infect
filovirus
bodi
recent
find
identifi
event
associ
filoviru
entri
provid
insight
uniqu
complex
entri
mechan
famili
envelop
virus
use
entri
initi
virion
attach
plasma
membran
lead
macropinocytosislik
intern
endosom
endosomallysosom
pathway
viral
glycoprotein
gp
undergo
proteolyt
cleavag
structur
rearrang
facilit
interact
host
factor
includ
essenti
intracellular
receptor
follow
interact
fusion
viral
host
membran
allow
releas
nucleocapsid
core
cytoplasm
viral
replic
elucid
seri
event
reveal
novel
hostviru
interact
led
identif
novel
therapeut
target
filovirus
discuss
current
understand
filoviru
entri
recent
develop
therapeut
target
viral
entri
process
filovirus
form
uniqu
filament
viru
particl
surround
membran
acquir
viral
bud
host
cell
plasma
membran
studi
indic
phosphatidylserin
ptdser
expos
outer
leaflet
virion
membran
presenc
ptdser
import
viru
attach
cell
surfac
within
virion
rna
genom
surround
protect
nucleocapsid
complex
compos
nucleoprotein
np
viral
polymeras
thought
recruit
complex
interact
major
minor
matrix
protein
respect
control
viru
morphogenesi
stud
inner
leaflet
viral
membran
recent
structur
protein
also
implic
regul
filoviru
rna
synthesi
viral
gp
viral
encod
protein
present
outer
surfac
virion
mediat
virushost
membran
fusion
filoviru
gp
class
viral
membran
fusion
gp
similar
env
influenza
viru
hemagglutinin
ha
recent
review
major
product
express
ebov
gp
gene
secret
solubl
gp
sgp
function
sgp
still
unclear
thought
import
viral
immun
evas
recent
review
full
length
membraneassoci
ebov
gp
produc
rna
frame
shift
result
insert
nontempl
adenosin
residu
transcript
rna
edit
contrast
marburgviru
gp
gene
directli
encod
membraneassoci
gp
equival
solubl
form
marburgviru
gp
thought
express
matur
filovir
gp
form
posttransl
furin
cleavag
proprotein
produc
disulfidelink
heterodim
compos
subunit
requir
receptor
interact
transmembraneassoci
requir
membran
fusion
like
class
viral
membran
fusion
gp
filoviru
gp
found
virion
trimer
crystal
structur
ebolaviru
speci
marburgviru
gp
ectodomain
solv
gp
form
chalicelik
shape
trimer
heterodim
base
cup
filoviru
four
distinct
domain
base
receptorbind
domain
rbd
glycan
cap
mucinlik
domain
mld
base
interact
provid
structur
support
domain
residu
within
rbd
interact
intracellular
cellular
receptor
niemannpick
within
late
endosomallysosom
compart
mld
glycan
cap
heavili
glycosyl
nlink
glycan
mld
also
contain
mani
olink
glycan
glycan
import
shield
gp
neutral
antibodi
unlik
mani
class
viral
gp
filoviru
fusion
peptid
resid
loop
near
ntermin
sequenc
rather
directli
nterminu
amino
acid
ebov
fusion
loop
clamp
disulfid
bond
membraneseek
hydrophob
sequenc
tip
loop
within
prefus
form
gp
hydrophob
loop
sequenc
protect
residu
adjac
subunit
fusion
event
unfold
addit
fusion
loop
contain
two
canon
helic
repeat
ectodomain
well
transmembran
domain
short
cytoplasm
tail
sever
cell
surfac
protein
identifi
mediat
attach
filovirus
evid
suggest
molecul
respons
viru
entri
endosom
ctype
lectin
clec
interact
nand
olink
glycan
gp
ptdser
receptor
interact
ptdser
present
viral
envelop
recent
review
fig
cell
surfac
protein
serv
canon
envelop
viru
receptor
interact
filoviru
gp
rbd
amino
acid
instead
protein
interact
filovirus
unconvent
mechan
discuss
outsid
host
cell
filoviru
gp
rbd
remain
mask
conform
unavail
receptor
interact
upon
proteolyt
process
within
endosom
compart
convent
filoviru
gpreceptor
interact
made
possibl
date
clec
includ
dendrit
cellspecif
nonintegrin
dcsign
liverlymph
nodespecif
grab
nonintegrin
lsign
lymph
node
sinusoid
endotheli
cell
ctype
lectin
lsectin
asialoglycoprotein
receptor
asgpri
human
macrophag
galactoseand
acetylgalactosaminespecif
ctype
lectin
hmgl
identifi
bind
nand
olink
glycan
ebov
gp
facilit
viru
entri
varieti
cell
dcsign
lsign
express
cell
myeloid
lineag
liverlymph
node
endotheli
cell
respect
sever
group
demonstr
highmannos
nlink
glycan
ebov
gp
interact
dclsign
facilit
entri
nacetylglucosamin
import
ebov
entri
mediat
lsectin
express
sinusoid
endotheli
cell
liver
lymph
node
along
vitro
matur
dc
macrophag
mous
lsectin
mous
dcsign
shown
mimic
properti
human
homolog
suggest
mice
lack
lsectin
receptor
could
util
infect
studi
better
defin
role
clec
vivo
two
clec
famili
member
known
enhanc
filoviru
infect
asgpri
hmgl
express
hepatocyt
monocytederiv
immatur
dendrit
cell
macrophag
respect
function
ebov
entri
factor
bind
specif
galactos
nacetylgalactosamin
role
ebov
gp
nlink
glycan
clecdepend
entri
recent
evalu
elimin
nlink
glycan
mutagenesi
mld
core
glycan
cap
gp
profoundli
decreas
viru
entri
mediat
cell
ectop
express
either
dcsign
lsign
surprisingli
given
observ
combin
remov
nlink
glycan
abrog
transduct
clec
demonstr
import
glycan
interact
clec
interestingli
lsectindepend
entri
less
affect
loss
nlink
glycan
core
glycan
cap
loss
nlink
glycan
mld
abolish
lsectindepend
viru
entri
impact
ebov
gp
nlink
glycan
asgprior
hmgldepend
entri
quit
differ
profil
remov
nglycan
mld
core
gp
decreas
ebov
entri
mediat
twofold
entri
hmgl
modestli
affect
nlink
glycan
loss
find
provid
evid
mld
olink
glycan
rather
ebov
nlink
glycan
critic
interact
clec
subset
ptdser
receptor
shown
enhanc
entri
varieti
envelop
virus
filovirus
lsectin
thought
exist
dimer
rather
tetram
cell
surfac
ptdser
receptor
tim
tam
famili
member
interact
ptdser
present
virion
envelop
ptdser
bind
pocket
tim
famili
complex
ptdser
bind
protein
protein
tam
famili
follow
interact
cell
surfac
protein
virion
enter
endosom
pathway
macropinocytosistyp
uptak
mechan
within
endosom
compart
filoviru
gp
cleav
cystein
proteas
includ
cathepsin
b
l
expos
receptorbind
domain
rbd
filoviru
gp
exposur
rbd
allow
gp
interact
lumin
cdomain
intracellular
receptor
virion
interact
twopor
ca
channel
tpc
play
import
role
late
entri
event
potenti
addit
proteolysi
event
may
also
requir
fusion
occur
exact
step
lead
fusion
remain
unknown
fusion
releas
viral
ribonucleoprotein
complex
cytoplasm
replic
therapeut
current
investig
abil
block
filoviru
entri
indic
step
thought
inhibit
alphavirus
flavivirus
bind
virionassoci
ptdser
date
six
ptdsermedi
virusentryenhanc
receptor
pveer
identifi
tcell
immunoglobulin
mucin
domain
tim
directli
bind
ptdser
virion
wherea
tam
famili
tyrosin
kinas
receptor
axl
mer
complex
protein
bind
ptdser
complex
compos
integrin
anoth
pveer
shown
facilit
uptak
lentivir
particl
bear
modifi
sindbi
viru
gp
detail
ptdser
receptor
viru
entri
recent
review
mollertank
mauri
although
clec
pveer
demonstr
enhanc
viru
attach
infect
specif
mechan
factor
induc
intern
viru
particl
remain
unknown
also
rel
import
clec
pveer
vivo
yet
explor
remain
unknown
whether
loss
one
protein
impact
filoviru
infect
protein
suffici
redund
function
loss
individu
would
littl
consequ
viru
entri
determin
import
receptor
vivo
may
allow
develop
antibodi
small
molecul
inhibit
filoviru
infect
cellular
attach
follow
attach
virion
intern
endosom
compart
macropinocytosi
thought
primari
uptak
mechan
rout
uptak
includ
caveolinand
clathrindepend
endocytosi
also
report
recent
review
remain
possibl
uptak
mechan
use
may
cell
type
depend
andor
cell
surfac
receptor
depend
differ
celldepend
mechan
entri
support
observ
african
green
monkey
epitheli
cell
vero
human
neuroblastoma
cell
primarili
use
macropinocytosi
viral
uptak
signal
pathway
requir
uptak
differ
filoviru
entri
vero
cell
primarili
exclus
mediat
requir
signal
phosphoinositid
akt
pathway
contrast
entri
cell
surfac
express
tam
tyrosin
kinas
axl
phospholipas
c
signal
requir
current
known
requisit
signal
directli
tie
virion
interact
specif
receptor
signal
requir
downstream
initi
cell
surfac
interact
recent
also
observ
ampactiv
protein
kinas
ampk
import
one
earli
step
ebov
entri
varieti
differ
cell
type
detail
role
ampk
entri
remain
elucid
evid
suggest
filovirus
traffic
cell
surfac
earli
endosom
late
endosom
lysosom
compart
viral
membran
fuse
cellular
membran
mediat
viral
genom
entri
cytoplasm
recent
studi
demonstr
releas
viral
genom
slow
presum
due
need
ebov
traffic
late
endosomallysosom
compart
upon
initi
intern
ebov
coloc
earli
endosom
posit
vesicl
gtpase
involv
traffick
virion
late
endosom
later
time
entri
virion
local
perinuclear
late
endosom
dominantneg
inhibitor
reduc
infect
suggest
import
ebov
entri
addit
gtpase
also
implic
ebov
endocytosi
includ
rhob
along
involv
gtpase
endosom
traffick
host
protein
signal
pathway
suggest
involv
virion
traffick
includ
homotyp
fusion
vacuol
proteinsort
hop
multisubunit
tether
complex
calciumcalmodulin
kinas
requir
event
filoviru
attach
fusion
numer
remain
incomplet
character
yet
fulli
map
endosom
rout
filovirus
travel
reach
site
viral
fusion
filoviru
gp
requir
proteolyt
cleavag
expos
rbd
gener
fusionreadi
form
protein
ebov
event
occur
within
endosomallysosom
pathway
earli
endosom
matur
late
endosom
acidifi
compart
activ
endosom
cystein
proteas
cathepsin
l
b
lowphdepend
proteas
remov
heavili
glycosl
mld
glycan
cap
produc
protein
interestingli
proteas
bacteri
thermolysin
effect
substitut
cathepsin
vitro
vivo
total
studi
indic
ebov
gp
proteolyt
process
requir
step
entri
process
cathepsin
b
l
mediat
effici
process
filovirus
proteas
neither
specif
absolut
requir
proteolyc
cleav
expos
rbd
ebov
gp
abl
interact
intracellular
receptor
interestingli
sever
studi
suggest
entri
proteolyt
process
ebov
remain
sensit
broadspectrum
cystein
proteas
inhibitor
suggest
addit
format
kda
form
gp
addit
proteaserequir
step
need
fusion
occur
identifi
host
protein
requir
filoviru
entri
two
independ
screen
studi
recent
review
larg
multipass
membran
protein
marker
specif
late
endosom
lysosom
compart
physiolog
role
protein
traffick
cholesterol
role
ebov
entri
independ
role
cholesterol
traffick
sinc
cell
lack
mutant
defect
cholesterol
traffick
still
abl
mediat
ebov
infect
consist
cell
biochem
knockdown
result
inhibit
ebov
entri
tissu
cultur
furthermor
heterozygot
mice
display
decreas
mortal
compar
wildtyp
mice
challeng
mouseadapt
ebov
interact
proteolyt
cleav
gp
specif
lumin
c
domain
recent
shown
ebov
vlp
traffick
late
endosom
lysosom
tempor
correl
viralcellular
membran
fusion
event
suggest
entri
compart
key
ratedefin
step
ebov
entri
fusion
may
occur
vesicl
addit
recent
studi
suggest
upon
entri
ebov
particl
coloc
endosom
compart
consist
possibl
virion
bhandoffbetween
two
receptor
propos
import
filoviru
entri
defin
parallel
work
establish
role
ltype
calcium
channel
entri
specif
ltype
channel
drug
verapamil
tetrandrin
nimodipin
diltiazem
inhibit
calcium
signal
induc
nicotin
acid
adenin
dinucleotid
phosphat
naadp
block
ebov
infect
channel
known
twopor
ca
channel
tpc
found
late
endosom
compart
also
addit
activ
tpc
requir
ebov
fusion
ebov
particl
accumul
compart
upon
tetrandrin
treatment
lead
author
suggest
compart
downstream
doubleposit
compart
may
serv
vesicl
virion
releas
cytoplasm
trigger
membran
fusion
remain
unknown
fusion
ebov
virion
endosomallysosom
compart
thought
similar
virus
class
fusion
gp
conform
chang
proteolyt
process
gp
expos
fusion
loop
result
insert
fusion
loop
hydrophob
residu
vesicular
membran
recent
studi
demonstr
conform
hydrophob
tip
loop
chang
low
ph
condit
presum
exist
vesicular
environ
mutat
two
hydrophob
residu
fusion
loop
compromis
viru
fusion
suggest
residu
critic
form
consolid
hydrophob
surfac
tip
loop
upon
loop
insert
vesicular
membran
unwind
trimer
caus
refold
helic
region
sixhelix
bundl
pull
host
viral
membran
proxim
fusion
fusion
allow
releas
viral
rna
associ
viral
protein
cytoplasm
downstream
viral
process
fig
smallmolecul
inhibitor
search
effect
therapeut
broadli
specif
block
filoviru
famili
member
mani
group
explor
abil
small
molecul
inhibitor
interfer
specif
step
viral
entri
process
recent
review
drug
explor
current
target
event
occur
within
endosom
proteolysi
filoviru
gp
endosom
traffick
interact
fusion
addit
sever
nonspecif
cystein
proteas
leupeptin
cathepsin
bl
inhibitor
fydmk
investig
abil
inhibit
ebov
infect
vitro
recent
anoth
cystein
proteas
inhibitor
identifi
inhibit
eboventri
tissu
cultur
subnanomolar
concentr
effect
safe
sarscov
mous
infect
effect
proteas
inhibitor
vivo
remain
elucid
howev
efficaci
compound
may
translat
vivo
studi
sinc
note
cathepsin
b
l
dispens
vivo
ebov
replic
consequ
inhibitor
specif
enzym
like
prove
efficaci
filovirus
vivo
sever
drug
investig
abil
inhibit
ebov
entri
target
late
endosom
event
includ
interact
cation
amphiphil
induc
loss
function
halt
cholesterol
transport
poorli
understood
mechan
reduc
ebov
infect
vitro
cation
amphiphil
shown
similar
effect
ebov
entri
cholesterol
accumul
provid
evid
broad
spectrum
compound
least
efficaci
ebov
entri
exampl
tertiari
amin
imipramin
interfer
cholesterol
sphingomyelin
transport
inhibit
acid
sphingomyelinas
activ
reduc
ebov
infect
vitro
third
compound
also
shown
effect
inhibit
ebov
entri
vitro
report
directli
interact
set
relat
estrogen
receptor
inhibitor
also
cation
amphiphil
identifi
vitro
screen
fdaapprov
molecul
efficaci
ebov
within
panel
drug
clomiphen
toremifen
shown
protect
mouseadapt
ebov
vivo
select
estrogen
receptor
modul
inhibit
ebov
mechan
independ
abil
interact
estrogen
seem
affect
late
entri
event
perhap
manner
similar
abil
drug
becom
potenti
human
filoviru
therapeut
reli
futur
work
focus
determin
detail
mechan
viral
inhibit
along
determin
efficaci
vivo
calciumcalmodulin
kinas
initi
identifi
sirna
screen
host
protein
critic
ebov
infect
calmodulin
inhibitor
profoundli
inhibit
entri
ebov
gp
pseudotyp
lentivir
vector
reduc
wildtyp
ebov
viral
titer
verapamil
tetradrin
nimodipin
diltiazem
inhibit
tpc
found
late
endosomelysosom
compart
discuss
mice
treat
tetradrin
signific
decreas
morbid
mortal
reduc
viral
titer
tpc
inhibitor
need
studi
show
promis
antivir
efficaci
monoclon
antibodi
therapi
ebov
entri
recent
antibodi
bind
ebov
gp
shown
effect
protect
nhp
lethal
ebov
challeng
neutral
monoclon
antibodi
mab
isol
human
ebov
survivor
util
crystallographi
studi
elucid
ebov
gp
structur
bind
base
prefus
neutral
infect
vitro
region
gp
term
bhot
spotfor
neutral
due
identif
number
monoclon
antibodi
bind
region
includ
antisudv
antibodi
interestingli
alon
protect
mice
guinea
pig
lethal
infect
protect
nhp
recent
combin
differ
antiebov
gp
mab
shown
protect
nhp
lethal
challeng
ebov
administ
follow
infect
one
effect
cocktail
mappbio
includ
antigp
antibodi
zmab
defyru
includ
antigp
antibodi
two
cocktail
combin
make
zmapp
develop
ebov
therapeut
map
epitop
antibodi
shown
bind
glycan
cap
wherea
bind
interfac
similar
region
latter
mab
within
cocktail
effect
neutral
viru
infect
vitro
studi
demonstr
combin
antibodi
target
interfac
glycan
cap
ebov
gp
effect
provid
protect
vivo
mani
mechanist
question
antibodi
work
inhibit
filoviru
infect
remain
unansw
futur
work
explor
abil
cocktail
protect
ebolaviru
speci
develop
similar
cocktail
speci
current
cocktail
prove
ineffect
furthermor
studi
need
determin
mechan
protect
provid
glycan
cap
antibodi
investig
abil
antibodi
interact
solubl
gp
addit
perhap
importantli
need
determin
readili
viru
evolv
mutat
within
target
epitop
therebi
escap
inhibit
antibodi
recent
advanc
filoviru
entri
research
provid
valuabl
insight
develop
new
therapeut
past
year
field
elucid
sever
step
within
complic
filoviru
entri
pathway
includ
identif
ptdser
receptor
serv
nonspecif
viral
envelop
attachmentintern
factor
identif
novel
essenti
endosom
receptor
filovirus
establish
role
ltype
calcium
channel
entri
indepth
knowledg
filoviru
gp
express
structur
function
better
therapeut
target
entri
pathway
understand
detail
filoviru
entri
process
yet
complet
futur
work
explor
mechanist
detail
entri
step
protein
involv
vitro
along
defin
critic
role
vivo
infect
import
question
still
remain
answer
includ
follow
trigger
viral
intern
follow
viral
attach
cell
viru
alway
follow
endosom
compart
pathway
host
signal
pathway
involv
viral
intern
traffick
pathway
target
therapeut
sinc
filovirus
requir
cathepsin
b
l
proteas
process
gp
also
exact
role
play
fusion
isar
fusion
trigger
yet
identifi
develop
clear
understand
basic
cellular
viru
biolog
underli
entri
process
abl
develop
effect
safe
therapeut
halt
human
filoviru
infect
conflict
interest
statement
author
declar
conflict
interest
human
anim
right
inform
consent
articl
contain
studi
human
anim
subject
perform
author
paper
particular
interest
publish
recent
highlight
import
major
import
